Physiological and pharmacodynamic considerations for route of EPO administration

被引:0
|
作者
Besarab, A [1 ]
机构
[1] Robert C Byrd Hlth Sci Ctr, Div Nephrol, Dept Med, Morgantown, WV 26506 USA
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:364 / 374
页数:11
相关论文
共 50 条
  • [21] PHARMACOKINETICS OF HALOPERIDOL AND CLOZAPINE WITH PHARMACODYNAMIC CONSIDERATIONS
    CHENG, YF
    ACTA PHARMACEUTICA NORDICA, 1989, 1 (06): : 373 - 374
  • [22] PHARMACODYNAMIC CONSIDERATIONS OF ATROPINE AND RELATED COMPOUNDS
    STOLL, HC
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1948, 215 (05): : 577 - 592
  • [23] Pharmacokinetic and pharmacodynamic considerations of retinoids: tretinoin
    Shapiro, SS
    Latriano, L
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 39 (02) : S13 - S16
  • [24] Relevance of the Alexander Project: Pharmacodynamic considerations
    Drusano, GL
    Goldstein, FW
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 38 : 141 - 154
  • [25] Pharmacodynamic and pharmacokinetic considerations in geriatric psychopharmacology
    Catterson, ML
    Preskorn, SH
    Martin, RL
    PSYCHIATRIC CLINICS OF NORTH AMERICA, 1997, 20 (01) : 205 - &
  • [26] Physiological, pharmacokinetic, and pharmacodynamic changes in space
    Graebe, A
    Schuck, EL
    Lensing, P
    Putcha, L
    Derendorf, H
    JOURNAL OF CLINICAL PHARMACOLOGY, 2004, 44 (08): : 837 - 853
  • [27] Intraperitoneal administration of local anesthetics in laparoscopic surgery: pharmacological, anatomical, physiological and pathophysiological considerations
    Ioannidis, O.
    Anastasilakis, C. D.
    Varnalidis, I.
    Paraskevas, G.
    Malakozis, S. G.
    Gatzos, S.
    Ntoumpara, M.
    Tsigkriki, L.
    Papapostolou, D.
    Makrantonakis, A.
    Papadopoulou, A.
    Makrantonakis, N.
    MINERVA CHIRURGICA, 2013, 68 (06) : 599 - 612
  • [28] USE OF A LIMITED PHYSIOLOGICAL MODEL TO EXPLAIN TARGET ORGAN TOXICITY OF BUPIVACAINE AS A FUNCTION OF ROUTE OF ADMINISTRATION
    DENSON, DD
    THOMPSON, GA
    COYLE, DE
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1986, 7 (02) : 121 - 135
  • [29] Pharmacodynamic modeling of prolonged administration of etoposide
    Minami, H
    Ratain, MJ
    Ando, Y
    Shimokata, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 39 (1-2) : 61 - 66
  • [30] PHARMACODYNAMIC ASPECTS OF INTRAVENOUS DILTIAZEM ADMINISTRATION
    JOYAL, M
    PIEPER, J
    CREMER, K
    FELDMAN, RL
    PEPINE, CJ
    AMERICAN HEART JOURNAL, 1986, 111 (01) : 54 - 61